Carfilzomib
Carfilzomib (PR-171) is a next generation, irreversible and selective inhibitor of the chymotrypsin-like activity of the proteasome. It displays potent antineoplastic activity.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20 ̊C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx146853 100 µg
PMS1 Homolog 1, Mismatch Repair System Component (PMS1) Antibody
Sign In for Pricing
View Details 
RC225682L4V 200 µL
MSF (SEPT9) (NM_001113492) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details